Anti-Helicobacter pylori and Anti-Inflammatory Effects and Constituent Analysis of Modified Xiaochaihutang for the Treatment of Chronic Gastritis and Gastric Ulcer
Table 10
The prototype components and metabolites detected from plasma of mice after administration of MXCHT’s -BuOH extract.
Number
/min
MS data in ESI+
MS data in ESI−
Identification
M1
4.014
433.12, 257.08
431.10, 255.06
Liquiritigenin-glu acid
M2
4.216
433.11, 257.08
431.10, 255.07
Liquiritigenin-glu acid
P1
4.283
549.16, 531.15, 483.13, 429.10, 393.10
547.15, 457.12, 427.12, 367.08, 337.07
Chrysin-6-C-glu-8-C-ara
M3
5.878
-
621.11, 445.08, 269.04
Baicalein-diglu acid
M4
6.164
637.14, 461.11, 285.08
635.12, 459.10, 283.06, 268.03
Wogonin-diglu acid
M5
8.515
433.11, 257.08
431.10, 255.06
Isoliquiritigenin-glu acid
M6
8.985
461.11, 285.07
459.09, 283.06, 268.04
Wogonin-5-O-glu acid
P2
9.267
461.12, 483.09, 285.08
459.10, 283.06, 113.02
Oroxylin A-7--glu acid
P3
9.926
-
445.08, 269.04
Baicalein-5--glu acid
P4
9.993
-
429.08, 253.05
Chrysin-glu acid
P5
10.161
477.11, 301.07
475.09, 299.06, 284.03
Trihydroxy-methoxy-glu acid flavone
P6
11.484
461.11, 483.09, 285.08
459.10, 283.06
Wogonoside
ESI, electrospray ionization source; MS, mass spectrometry; P, prototype components; M, metabolites; glu acid, glucuronic acid.
